Clinical trial
Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in…
NCT00160030 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00160030 |
|---|---|
| Title | Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer |
| Official title | Phase II Study Comparing Radiochemotherapy With the Folfox 4 Regimen Versus Radiochemotherapy With 5FU-Cisplatin (Herskovic Regimen) in First Line Treatment of Patients With Inoperable Esophageal Cancer |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Neoplasms |
| Intervention type | Drug |
| Interventions | FOLFOX 4, 5-FU / Cisplatin |
| Enrollment | 97 |
| Start date | Sep 1, 2004 |
| Primary completion | Oct 1, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Dec 7, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: